AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+2.24%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.12B
AUM Growth
+$3.12B
(+40%)
Cap. Flow
+$814M
Cap. Flow
% of AUM
26.08%
Top 10 Holdings %
Top 10 Hldgs %
27.7%
Holding
147
New
41
Increased
50
Reduced
12
Closed
36
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$84.2M |
| 2 |
TJX Companies
TJX
|
$74.6M |
| 3 |
Amazon
AMZN
|
$61.6M |
| 4 |
Travere Therapeutics
TVTX
|
$58.8M |
| 5 |
Advance Auto Parts
AAP
|
$50.2M |
Top Sells
| 1 |
Lantheus
LNTH
|
$53.4M |
| 2 |
O'Reilly Automotive
ORLY
|
$41M |
| 3 |
Ulta Beauty
ULTA
|
$39.7M |
| 4 |
Five Below
FIVE
|
$38.4M |
| 5 |
Frontdoor
FTDR
|
$32.9M |
Sector Composition
| 1 | Healthcare | 65.24% |
| 2 | Consumer Staples | 14.09% |
| 3 | Consumer Discretionary | 13.47% |
| 4 | Technology | 3.01% |
| 5 | Industrials | 2.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Clorox
CLX
$15B
| $48.2M | 1.11% |
250,000
+190,000
| +317% | +$36.6M |
|
27
Campbell Soup
CPB
$10.1B
| $46.4M | 1.07% |
924,000
+156,000
| +20% | +$7.84M |
|
28
Catalyst Pharmaceutical
CPRX
$2.42B
| $46.1M | 1.06% |
10,000,000
| – | – |
|
29
AB InBev
BUD
$116B
| $44M | 1.01% |
+700,000
| New | +$44M |
|
30
Pfizer
PFE
$141B
| $43.5M | 1% |
+1,200,000
| New | +$43.5M |
|
31
Nike
NKE
$110B
| $42.9M | 0.98% |
+322,491
| New | +$42.9M |
|
|
OCDX
32
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $42.4M | 0.97% |
+2,196,000
| New | +$42.4M |
|
33
argenx
ARGX
$44.2B
| $41.3M | 0.95% |
150,000
+70,000
| +88% | +$19.3M |
|
34
Central Garden & Pet Class A
CENTA
$2.11B
| $41.1M | 0.94% |
792,000
-272,000
| -26% | -$14.1M |
|
35
Madrigal Pharmaceuticals
MDGL
$9.7B
| $40.9M | 0.94% |
350,000
+34,000
| +11% | +$3.98M |
|
36
Ralph Lauren
RL
$19B
| $35.8M | 0.82% |
+290,517
| New | +$35.8M |
|
37
Alibaba
BABA
$325B
| $34.9M | 0.8% |
154,000
+50,000
| +48% | +$11.3M |
|
|
SPPI
38
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $34.9M | 0.8% |
10,700,000
+1,108,000
| +12% | +$3.61M |
|
39
Mondelez International
MDLZ
$79.3B
| $31.4M | 0.72% |
536,000
+144,000
| +37% | +$8.43M |
|
40
BioNTech
BNTX
$24.1B
| $30.1M | 0.69% |
276,000
+40,000
| +17% | +$4.37M |
|
41
DexCom
DXCM
$30.9B
| $29.5M | 0.68% |
82,000
+18,000
| +28% | +$6.47M |
|
|
PARA
42
DELISTED
Paramount Global Class B
PARA
| $28.1M | 0.65% |
+624,000
| New | +$28.1M |
|
43
Thermo Fisher Scientific
TMO
$183B
| $26.5M | 0.61% |
58,000
+19,000
| +49% | +$8.67M |
|
|
NUVA
44
DELISTED
NuVasive, Inc.
NUVA
| $26.2M | 0.6% |
400,000
-140,000
| -26% | -$9.18M |
|
45
Adobe
ADBE
$148B
| $25.7M | 0.59% |
54,000
+42,000
| +350% | +$20M |
|
46
Microsoft
MSFT
$3.76T
| $25.5M | 0.58% |
108,000
+50,000
| +86% | +$11.8M |
|
47
Natera
NTRA
$23B
| $25.2M | 0.58% |
248,000
+132,000
| +114% | +$13.4M |
|
|
AXNX
48
DELISTED
Axonics, Inc. Common Stock
AXNX
| $25M | 0.57% |
418,000
+170,000
| +69% | +$10.2M |
|
49
Tractor Supply
TSCO
$31.9B
| $23.5M | 0.54% |
+132,737
| New | +$23.5M |
|
50
Bio-Rad Laboratories Class A
BIO
$7.8B
| $21.7M | 0.5% |
38,000
+5,000
| +15% | +$2.86M |
|